Latest Articles

Publication Date
Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy - Labroots

Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy Labroots

Published: July 14, 2025, 10 a.m.
Disease Severity- and Hormonal Status-Dependent Alterations of EGF and MIF in the Serum of Endometriosis Patients.

Endometriosis is the extrauterine engraftment of endometrium-like tissue, causing chronic pain. Complex sensory-vascular-immune interactions, including growth factors, cytokines, and neuropeptides, are implicated in its pathophysiology, but the mechanisms remain unknown. …

Published: July 12, 2025, midnight
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer - OncLive

Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer OncLive

Published: July 11, 2025, 6:17 p.m.
Organon to drop pain therapy program after trial setback - MSN

Organon to drop pain therapy program after trial setback MSN

Published: July 3, 2025, 8:43 p.m.
Acupuncture as an Adjunct Therapy for Enhancing Endometrial Receptivity in Female Infertility : A Literature Review - Frontiers

Acupuncture as an Adjunct Therapy for Enhancing Endometrial Receptivity in Female Infertility : A Literature Review Frontiers

Published: July 3, 2025, 6:16 p.m.
Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers - MedPage Today

Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers MedPage Today

Published: July 3, 2025, 3 p.m.
Certain type of hormone therapy increases breast cancer risk, study finds - CBS News

Certain type of hormone therapy increases breast cancer risk, study finds CBS News

Published: July 3, 2025, 12:59 a.m.
Endometrial Cancer - Pipeline Insight, 2025: Immunotherapy - openPR.com

Endometrial Cancer - Pipeline Insight, 2025: Immunotherapy openPR.com

Published: June 30, 2025, 6:49 p.m.
Changes in the M1/M2 ratio due to andrographolide therapy for deep endometriosis: An experimental study using a BALB/C endometriosis model.

Andrographolide is a compound that serves as an anti-inflammatory agent. M2 macrophages promote the disease, while M1 macrophages inhibit endometriosis progression.

Published: June 30, 2025, midnight
Molecular profiling reduces need for radiotherapy in endometrial cancer - Contemporary OB/GYN

Molecular profiling reduces need for radiotherapy in endometrial cancer Contemporary OB/GYN

Published: June 24, 2025, 5:47 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!